Drugs that contain Albuterol Sulfate; Budesonide

1. Airsupra patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9415009 ASTRAZENECA Compositions, methods and systems for respiratory delivery of two or more active agents
May, 2030

(6 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jan 10, 2026

Market Authorisation Date: 10 January, 2023

Treatment: As-needed treatment or prevention of bronchoconstriction and reduction of the risk of exacerbations in patients with asthma 18 years of age and older


More Information on Dosage

AIRSUPRA family patents

Family Patents